Renzhong Lu (Ke-He Ruan)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Pulmonary Arterial Hypertension

Nitric Oxide Synthase

Top Venues

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Renzhong Lu, Hironori Akasaka
Design, synthesis and characterization of lead compounds as anti-inflammatory drugs targeting mPGES-1 via enzymelink screening. Future medicinal chemistry (2023)
Renzhong Lu
Latest advancements in the study of the relationship between NSAIDs and three prostaglandin E2 synthases. Future medicinal chemistry (2023)
Krista LaBorde, Renzhong Lu, Ke-He Ruan
Latest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E 2 synthase-1. Future medicinal chemistry 14 (6) (2022)
Diana T Ruan, Renzhong Lu, Ke-He Ruan
Redirecting thromboxane A2 and prostacyclin biosyntheses from thrombotic to antithrombotic property by an Enzymelink. Future medicinal chemistry 13 (9) (2021)
Diana T Ruan, Nanhong Tang, Hironari Akasaka, Renzhong Lu, Ke-He Ruan
Engineering 'Enzymelink' for screening lead compounds to inhibit mPGES-1 while maintaining prostacyclin synthase activity. Future medicinal chemistry 13 (13) (2021)
Karishma Thakkar, Cheng-Huai Ruan, Renzhong Lu
Recent advances of cannabidiol studies in medicinal chemistry, pharmacology and therapeutics. Future medicinal chemistry 13 (22) (2021)